Divis Laboratories Ltd | DIVI - Operating Expenses

Stock Price
6,758.00
Daily Change
-163.50 -2.36%
Monthly
7.38%
Yearly
7.62%
Q2 Forecast
6,560.86

Divis Laboratories Ltd reported INR18.32B in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
Alaunos Therapeutics USD 1.19M 148K Sep/2025
Aurobindo Pharma INR 73.37B 3.01B Dec/2025
Avita Medical AUD 28.02M 1.55M Dec/2025
Dianthus Therapeutics USD 69.82M 29.14M Dec/2025
Divis Laboratories Ltd INR 18.32B 1.08B Dec/2025
Ionis Pharmaceuticals USD 364M 54M Mar/2026
IQVIA Holdings USD 6.22B 4.53B Mar/2026
Lupin INR 52.71B 443.1M Dec/2025
Moderna USD 1.78B 242M Mar/2026
Organon & Co USD 903M 387M Mar/2026
Revvity USD 628.34M 2.12M Mar/2026
Tectonic Therapeutic USD 21.52M 374K Dec/2025
Tilray USD 237.52M 17.34M Sep/2025
Viatris USD 3.54B 323.9M Mar/2026
Xeris Pharmaceuticals USD 69.03M 1.38M Dec/2025